Add like
Add dislike
Add to saved papers

Outcome of open Tenckhoff catheter insertions: 5 years experience in a major tertiary centre in central Saudi Arabia.

BACKGROUND: Continuous ambulatory peritoneal dialysis (CAPD) has become a popular and established form of renal replacement therapy in patients with end-stage renal disease (ESRD). The objective of this study was to analyse the outcome of open Tenckhoff catheter insertions in patients with ESRD in term of catheter related complications.

METHODS: From December 2006 to November 2011, 337 Tenckhoff catheters were placed in 305 patients with ESRD for CAPD, by general surgeons in King Saud Medical City, Riyadh, Saudi Arabia. Medical record of all these patients was reviewed retrospectively regarding the demography, causes of ESRD, catheter related complications, and their management.

RESULTS: Mean age of the patients was 51.2 +/- 14.5 (range, 16-87 years). Majority of the patients were female 164 (53.7%). Forty three patients (14.1%) had previous abdominal surgery. Diabetic nephropathy was the commonest (51.4%) primary cause of ESRD. Ninety three insertions (27.5%) were associated with complications. Post insertion peritonitis was the commonest complication (9.2%) in our series, followed by mechanical dysfunction (8.6%). Fifty two catheters (15.4%) were removed because of different complications. Follow up ranged between 4-47 months with a mean of 21.4 +/- 11.2 months.

CONCLUSIONS: Open surgical approach is simple, safe, and effective method of Tenckhoff catheter insertion with an acceptable complication rate, provided patients are adequately optimized and prepared for surgery.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app